American Scientific Resources, Incorporated
ASFX
$0.0001
$0.000.00%
| Weiss Ratings | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | -- | |||
| Risk Index | -- | |||
| Risk Grade | -- | |||
| Reward Grade | -- | |||
| Rating Factors | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | -- | |||
| Efficiency Index | -- | |||
| Solvency Index | -- | |||
| Total Return Index | -- | |||
| Volatility Index | -- | |||
| Beta / Standard Deviation | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -65.30 | |||
| Price History | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -66.67% | |||
| 52-Week High % Change | 0.00% | |||
| 52-Week Low % Change | 9,900.00% | |||
| Price | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Sep 03, 2024 | |||
| 52-Week High Price (Date) | Dec 18, 2024 | |||
| Valuation | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 41.70K | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -- | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | -- | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 847-386-1384 | |||
| Address | 1112 Weston Road Weston, FL 33326 | |||
| Website | -- | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -423.45% | |||
| Profit Margin | -877.44% | |||
| Management Effectiveness | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -133.75% | |||
| Return on Equity | -- | |||
| Income Statement | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.05M | |||
| Total Revenue (TTM) | 1.05M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 225.10K | |||
| EBITDA (TTM) | -4.33M | |||
| EBIT (TTM) | -4.43M | |||
| Net Income (TTM) | -9.18M | |||
| Net Income Avl. to Common (TTM) | -9.18M | |||
| Total Revenue Growth (Q YOY) | 65.39% | |||
| Earnings Growth (Q YOY) | 68.53% | |||
| EPS Diluted (TTM) | -0.76 | |||
| EPS Diluted Growth (Q YOY) | 81.27% | |||
| Balance Sheet | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 19.60K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 635.40K | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -7.95M | |||
| Current Ratio (Q) | 0.094 | |||
| Book Value Per Share (Q) | -- | |||
| Total Assets (Q) | -- | |||
| Total Current Liabilities (Q) | 6.75M | |||
| Total Debt (Q) | -- | |||
| Total Liabilities (Q) | -- | |||
| Total Common Equity (Q) | -7.95M | |||
| Cash Flow | ASFX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -20.30K | |||
| Cash from Financing (TTM) | 1.30M | |||
| Net Change in Cash (TTM) | 18.70K | |||
| Levered Free Cash Flow (TTM) | -2.20M | |||
| Cash from Operations (TTM) | -1.26M | |||
